A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

Community Health Network, Rochester

Guthrie Clinic, Sayre

George Washington Univ / Hershey Med Ctr, Washington D.C.

Independent Investigator, Vero Beach

Community Research Initiative of South Florida, Coral Gables

Independent Investigator, Fort Lauderdale

North Broward Hosp District, Fort Lauderdale

Clinical Research Ctr, Sarasota

Infectious Disease Associates, Toledo

Univ Health Ctr, Detroit

Ctr for Special Immunology, Chicago

Antibiotic Research Associates, Kansas City

Univ of Kansas School of Medicine, Wichita

New Orleans Institute of Clinical Investigation, New Orleans

Houston Clinical Research Network, Houston

Southwest Community Based AIDS Treatment Group - COMBAT, Los Angeles

California Clinical Trials Med Group, Beverly Hills

UCSF - San Francisco Gen Hosp, San Francisco

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

Clinical Investigations Health Services, Mobile

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

Univ TX Galveston Med Branch, Galveston

North Jersey Community Research Initiative, Newark